IDEntification of New Predisposition Genes in Differentiated THYroid Cancer (IDENTHY-K)
Sponsor: Nantes University Hospital
Terminated
end-of-study visit not completed within the protocol timeframe
Other terminated trials from Nantes University Hospital
Other Differentiated Thyroid Cancer trials with similar outcome
This NA trial investigates Differentiated Thyroid Cancer and Thyroid Cancer, Nonmedullary and is currently terminated or withdrawn. Nantes University Hospital leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2023 — Mar 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Apr 2022 — Jan 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Apr 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Nantes University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .